Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.

Rashed WM, Hamza MM, Matboli M, Salem SI.

Cancer Metastasis Rev. 2019 Dec 5. doi: 10.1007/s10555-019-09826-0. [Epub ahead of print] Review.

PMID:
31807971
2.

Role of a novel circulatory RNA-based biomarker panel expression in ovarian cancer.

El-Shal AS, Matboli M, Abdelaziz AM, Morsy AA, Abdelbary EH.

IUBMB Life. 2019 Dec;71(12):2031-2047. doi: 10.1002/iub.2153. Epub 2019 Sep 13.

PMID:
31520466
3.

Hesperidin suppressed hepatic precancerous lesions via modulation of exophagy in rats.

Hasanin AH, Matboli M, Seleem HS.

J Cell Biochem. 2020 Feb;121(2):1295-1306. doi: 10.1002/jcb.29363. Epub 2019 Sep 6.

PMID:
31489981
4.

Role of extracellular LncRNA-SNHG14/miRNA-3940-5p/NAP12 mRNA in colorectal cancer.

Matboli M, Shafei AE, Ali MA, El-Din Ahmed TS, Naser M, Abdel-Rahman T, Anber N, Ali M.

Arch Physiol Biochem. 2019 Aug 9:1-7. doi: 10.1080/13813455.2019.1650070. [Epub ahead of print]

PMID:
31397210
5.

Caffeic Acid Modulates miR-636 Expression in Diabetic Nephropathy Rats.

Salem AM, Ragheb AS, Hegazy MGA, Matboli M, Eissa S.

Indian J Clin Biochem. 2019 Jul;34(3):296-303. doi: 10.1007/s12291-018-0743-0. Epub 2018 Feb 26.

PMID:
31391719
6.

Correction to: Potential role of lncRNA-TSIX, miR-548-a-3p, and SOGA1 mRNA in the diagnosis of hepatocellular carcinoma.

Habieb A, Matboli M, El-Tayeb H, El-Asmar F.

Mol Biol Rep. 2019 Aug;46(4):4591. doi: 10.1007/s11033-019-04838-z.

PMID:
31049832
7.

Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2-acetamidofluorene.

Matboli M, ElGwad AA, Hasanin AH, El-Tawdi A, Habib EK, Elmansy RA, Ibrahim D, Shehata H, Tash F.

J Cell Biochem. 2019 Sep;120(9):14946-14959. doi: 10.1002/jcb.28757. Epub 2019 Apr 22.

PMID:
31009125
8.

Potential role of lncRNA-TSIX, miR-548-a-3p, and SOGA1 mRNA in the diagnosis of hepatocellular carcinoma.

Habieb A, Matboli M, El-Tayeb H, El-Asmar F.

Mol Biol Rep. 2019 Aug;46(4):4581-4590. doi: 10.1007/s11033-019-04810-x. Epub 2019 Apr 19. Erratum in: Mol Biol Rep. 2019 May 2;:.

PMID:
31004302
9.

Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.

Eissa S, Safwat M, Matboli M, Zaghloul A, El-Sawalhi M, Shaheen A.

Urol Oncol. 2019 Apr;37(4):292.e19-292.e27. doi: 10.1016/j.urolonc.2018.12.024. Epub 2019 Jan 14.

PMID:
30654976
10.

circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinoma.

Matboli M, Shafei AE, Ali MA, Ashry AM, Kamal KM, Agag MA, Reda I, Tash EF, Ali M.

J Cell Biochem. 2018 Nov 13. doi: 10.1002/jcb.28045. [Epub ahead of print]

PMID:
30426540
11.

Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma.

Matboli M, Shafei AE, Ali MA, Gaber AI, Galal A, Tarek O, Marei M, Khairy E, El-Khazragy N, Anber N, Abdel-Rahman O.

J Cell Biochem. 2019 Mar;120(3):3203-3211. doi: 10.1002/jcb.27586. Epub 2018 Oct 26.

PMID:
30362153
12.

Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma.

Abd El Gwad A, Matboli M, El-Tawdi A, Habib EK, Shehata H, Ibrahim D, Tash F.

J Cell Biochem. 2018 Nov;119(10):8600-8610. doi: 10.1002/jcb.27109. Epub 2018 Jul 17.

PMID:
30015383
13.

Emerging role of nutrition and the non-coding landscape in type 2 diabetes mellitus: A review of literature.

Matboli M, Shafei A, Ali M, Kamal KM, Noah M, Lewis P, Habashy A, Ehab M, Gaber AI, Abdelzaher H.

Gene. 2018 Oct 30;675:54-61. doi: 10.1016/j.gene.2018.06.082. Epub 2018 Jun 27. Review.

PMID:
29960068
14.

Competing endogenous RNA network crosstalk reveals novel molecular markers in colorectal cancer.

Samir N, Matboli M, El-Tayeb H, El-Tawdi A, Hassan MK, Waly A, El-Akkad HAE, Ramadan MG, Al-Belkini TN, El-Khamisy S, El-Asmar F.

J Cell Biochem. 2018 Aug;119(8):6869-6881. doi: 10.1002/jcb.26884. Epub 2018 May 8.

PMID:
29737552
15.

Dual approach for the colorimetric determination of unamplified microRNAs by using citrate capped gold nanoparticles.

Nossier AI, Abdelzaher H, Matboli M, Eissa S.

Mikrochim Acta. 2018 Mar 22;185(4):236. doi: 10.1007/s00604-018-2767-9.

PMID:
29594755
16.

Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma.

Ali MA, Matboli M, El-Khazragy N, Saber O, El-Nakeep S, Abdelzaher HM, Shafei AE, Mostafa R.

Biomark Med. 2018 Mar;12(3):245-256. doi: 10.2217/bmm-2017-0273. Epub 2018 Feb 14.

PMID:
29441798
17.

Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.

Matboli M, Shafei AE, Azazy AE, Reda M, El-Khazragy N, Nagy AA, Ali MA, Sobhi M, Abdel-Rahman O.

Biomark Med. 2018 Feb;12(2):129-139. doi: 10.2217/bmm-2017-0224. Epub 2018 Jan 17.

PMID:
29338319
18.

Clinical significance of miRNA-autophagy transcript expression in patients with hepatocellular carcinoma.

Matboli M, Shafei AE, Shehata HH, Nabil N, Hossam N, Azazy AE, El-Tawdi AH, Abdel-Rahman O.

Biomark Med. 2017 Aug;11(8):641-656. doi: 10.2217/bmm-2017-0049. Epub 2017 Aug 3.

PMID:
28770611
19.

Evaluation of urinary autophagy transcripts expression in diabetic kidney disease.

Matboli M, Azazy AEM, Adel S, Bekhet MM, Eissa S.

J Diabetes Complications. 2017 Oct;31(10):1491-1498. doi: 10.1016/j.jdiacomp.2017.06.009. Epub 2017 Jun 27.

PMID:
28760651
20.

Caffeic Acid Attenuates Diabetic Kidney Disease via Modulation of Autophagy in a High-Fat Diet/Streptozotocin- Induced Diabetic Rat.

Matboli M, Eissa S, Ibrahim D, Hegazy MGA, Imam SS, Habib EK.

Sci Rep. 2017 May 23;7(1):2263. doi: 10.1038/s41598-017-02320-z.

21.

Identification and validation of a novel autophagy gene expression signature for human bladder cancer patients.

Eissa S, Matboli M, Awad N, Kotb Y.

Tumour Biol. 2017 Apr;39(4):1010428317698360. doi: 10.1177/1010428317698360.

PMID:
28381171
22.

Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?

Ali MA, Matboli M, Tarek M, Reda M, Kamal KM, Nouh M, Ashry AM, El-Bab AF, Mesalam HA, Shafei AE, Abdel-Rahman O.

Immunotherapy. 2017 Jan;9(1):99-108. doi: 10.2217/imt-2016-0111. Review.

PMID:
28000527
23.

Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia.

Adel S, Mansour A, Louka M, Matboli M, Elmekkawi SF, Swelam N.

Gene. 2017 Jan 5;596:105-109. doi: 10.1016/j.gene.2016.10.014. Epub 2016 Oct 13.

PMID:
27746364
24.

Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.

Eissa S, Matboli M, Bekhet MM.

Biomed Pharmacother. 2016 Oct;83:92-99. doi: 10.1016/j.biopha.2016.06.018. Epub 2016 Jun 23.

PMID:
27470555
25.

Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease.

Eissa S, Matboli M, Aboushahba R, Bekhet MM, Soliman Y.

J Diabetes Complications. 2016 Nov - Dec;30(8):1585-1592. doi: 10.1016/j.jdiacomp.2016.07.012. Epub 2016 Jul 21.

PMID:
27475263
26.

Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.

Matboli M, El-Nakeep S, Hossam N, Habieb A, Azazy AE, Ebrahim AE, Nagy Z, Abdel-Rahman O.

World J Gastroenterol. 2016 Jul 14;22(26):5896-908. doi: 10.3748/wjg.v22.i26.5896. Review.

27.

Prophylactic L-arginine and ibuprofen delay the development of tactile allodynia and suppress spinal miR-155 in a rat model of diabetic neuropathy.

El-Lithy GM, El-Bakly WM, Matboli M, Abd-Alkhalek HA, Masoud SI, Hamza M.

Transl Res. 2016 Nov;177:85-97.e1. doi: 10.1016/j.trsl.2016.06.005. Epub 2016 Jun 23.

PMID:
27392937
28.

Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.

El-Tawdi AH, Matboli M, El-Nakeep S, Azazy AE, Abdel-Rahman O.

Expert Rev Gastroenterol Hepatol. 2016 Jul;10(7):869-77. doi: 10.1080/17474124.2016.1193003. Epub 2016 Jun 6.

PMID:
27215316
29.

Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma.

El-Tawdi AH, Matboli M, Shehata HH, Tash F, El-Khazragy N, Azazy Ael-S, Abdel-Rahman O.

Mol Diagn Ther. 2016 Jun;20(3):265-77. doi: 10.1007/s40291-016-0200-9.

PMID:
27113935
30.

Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.

Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AHF.

Transl Res. 2016 Feb;168:134-145. doi: 10.1016/j.trsl.2015.10.002. Epub 2015 Oct 24.

PMID:
26551349
31.

Prognostic and biological significance of microRNA-221 in breast cancer.

Eissa S, Matboli M, Sharawy A, El-Sharkawi F.

Gene. 2015 Dec 10;574(1):163-7. doi: 10.1016/j.gene.2015.08.004. Epub 2015 Aug 5.

PMID:
26253160
32.

Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay.

Eissa S, Matboli M, Essawy NO, Shehta M, Kotb YM.

Biomarkers. 2015;20(3):212-7. doi: 10.3109/1354750X.2015.1062918. Epub 2015 Jul 13.

PMID:
26161701
33.

Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.

Eissa S, Matboli M, Essawy NO, Kotb YM.

Tumour Biol. 2015 Dec;36(12):9545-52. doi: 10.1007/s13277-015-3722-6. Epub 2015 Jul 3.

PMID:
26138586
34.

Urine biomarkers of schistosomiais and its associated bladder cancer.

Eissa S, Matboli M, Shawky S, Essawy NO.

Expert Rev Anti Infect Ther. 2015 Aug;13(8):985-93. doi: 10.1586/14787210.2015.1051032. Epub 2015 Jun 23. Review.

PMID:
26105083
35.

Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis.

Eissa S, Matboli M, Hegazy MG, Kotb YM, Essawy NO.

Transl Res. 2015 Jun;165(6):731-9. doi: 10.1016/j.trsl.2014.12.008. Epub 2015 Jan 7.

PMID:
25620614
36.

MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer.

Eissa S, Matboli M, Shehata HH, Essawy NO.

Tumour Biol. 2015 Jun;36(6):4487-94. doi: 10.1007/s13277-015-3090-2. Epub 2015 Jan 18.

PMID:
25596707
37.

Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.

Eissa S, Matboli M, Shehata HH.

Transl Res. 2015 Mar;165(3):417-27. doi: 10.1016/j.trsl.2014.10.001. Epub 2014 Oct 31.

PMID:
25445205
38.

The prognostic value of histidine-rich glycoprotein RNA in breast tissue using unmodified gold nanoparticles assay.

Eissa S, Azzazy HM, Matboli M, Shawky SM, Said H, Anous FA.

Appl Biochem Biotechnol. 2014 Sep;174(2):751-61. doi: 10.1007/s12010-014-1085-x.

PMID:
25091325
39.

Evaluation of histidine-rich glycoprotein tissue RNA and serum protein as novel markers for breast cancer.

Matboli M, Eissa S, Said H.

Med Oncol. 2014 Apr;31(4):897. doi: 10.1007/s12032-014-0897-4. Epub 2014 Feb 25.

PMID:
24567057
40.

Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis.

Eissa S, Matboli M, Mansour A, Mohamed S, Awad N, Kotb YM.

Med Oncol. 2014 Feb;31(2):804. doi: 10.1007/s12032-013-0804-4. Epub 2013 Dec 28.

PMID:
24375315
41.

Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis.

Eissa S, Shawky SM, Matboli M, Mohamed S, Azzazy HM.

Clin Biochem. 2014 Jan;47(1-2):104-10. doi: 10.1016/j.clinbiochem.2013.10.022. Epub 2013 Oct 29.

PMID:
24183881

Supplemental Content

Loading ...
Support Center